AHI Applauds UN Declaration on AMR

September 27, 2024 The Animal Health Institute (AHI) welcomes the adoption of the United Nations political declaration on antimicrobial resistance (AMR).  The declaration represents a global consensus for better animal health and disease prevention.  Under the One Health approach, actions in animal health, human health and the environment present the best pathway for addressing AMR. […]

AHI Viewpoint: Reducing Antibiotic Resistance Calls for a One Health Approach

Antibiotics are a cornerstone of modern medicine. However, unnecessary use can lead to resistant bacterial infections where antibiotics may no longer work. Solving this challenge cuts across human, environmental, and animal health, and it requires action in all domains. Nearly 200 nations around the world are taking collective action to address the global health challenge […]

AHI Viewpoint: Judicious Use is Helping Reduce the Need for Animal Antibiotics

The animal health industry is committed to researching and producing a full spectrum of veterinary tools that reduce the need for antibiotics. In addition to preventing the diseases that call for antibiotic use, we are working to ensure that when antibiotics are used, they are used judiciously. The American Veterinary Medical Association (AVMA) has recognized […]

AHI Viewpoint: Disease Prevention is a Proven Pathway to Reducing the Need for Animal Antibiotics

The best strategy for reducing the threat of antimicrobial resistance is to reduce the need for antibiotics through better prevention, earlier detection, and more efficient treatment. Innovations in animal health have improved prevention efforts. For example, accurate diagnostics curb the severity of animal disease by enabling more effective treatments and reducing the need for antibiotics. […]

AHI President & CEO Alex Mathews to Retire

WASHINGTON, DC, July 18, 2024 – Alexander S. Mathews, President and CEO of the Animal Health Institute, has announced his intention to retire from that position at the end of the calendar year. As a result, the Board has initiated a nationwide search for a successor.   “The AHI Board extends its deepest gratitude to […]

AHI Statement Regarding FDA-CVM Clarification

July 16, 2024 The Animal Health Institute (AHI) commends the Food and Drug Administration’s Center for Veterinary Medicine (FDA-CVM) for its decisive action in clarifying the prioritization of approved pioneer and generic products by veterinarians and pharmacists before considering compounded or illegally imported products. The use of FDA-approved animal drug products should always be preferred. These […]

Ester Banque of Zoetis Elected AHI Board Chair

The Animal Health Institute’s Board of Directors today elected Ester Banque of Zoetis as Board Chair for the 2024-26 term. Banque is Executive Vice President and President, U.S. Operations for Zoetis.

AHI Position on Arizona’s mRNA Labeling Legislation

AHI encourages Arizona Governor Katie Hobbs to veto SB 1146, a bill that disparages life-saving vaccine technology by allowing food products from aquaculture, livestock, and poultry to be labeled “mRNA free” if the animals did not receive mRNA vaccinations. 

AHI Welcomes FDA Action on Unapproved Drugs

AHI welcomes the announcement of the Food and Drug Administration’s (FDA) action to issue warning letters to nine manufacturers and distributors who were marketing unapproved and misbranded antimicrobial animal drugs.

Congress Supports Animal Health with Passage of ADUFA

The Animal Health Institute today praised Congress for passing the reauthorization of the Animal Drug User Fee Act (ADUFA). ADUFA provides the Food and Drug Administration’s Center for Veterinary Medicine (CVM) with supplemental industry funds in exchange for meeting agreed-upon performance goals.